Friday, December 4, 2009
Lilly: FDA OKs Zyprexa For Schizophrenia In Teens; New Label - CNNMoney.com
Lilly: FDA OKs Zyprexa For Schizophrenia In Teens; New Label
CNNMoney.com
... problems such as diabetes and cardiovascular disease. Lilly's shares rose 1.3% to $37.88 in after-hours trading. The stock has gained 10% in the past year.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment